It is hard to get excited after looking at Salesforce's (NYSE:CRM) recent performance, when its stock has declined 21...
Disappointing Q1 results for Salesforce and a weak outlook raised questions over how soon software makers will monetize generative AI products.
Many tech-focused growth stocks were dumped by Big Money investors last week.